Deep Track Capital »

10x Genomics Inc Cl A shares owned by Deep Track Capital

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.5M 183k 41.25

More positions owned by Deep Track Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Intra Cellular Therapies (ITCI)
Ionis Pharmaceuticals (IONS)
Guardant Health (GH)
Immunovant (IMVT)
Alkermes SHS (ALKS)
Dynavax Technologies Corp Com New (DVAX)
Structure Therapeutics Sponsored Ads (GPCR)
Pliant Therapeutics (PLRX)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Travere Therapeutics (TVTX)
Intellia Therapeutics (NTLA)

View all positions for Deep Track Capital

Top funds holding 10x Genomics Inc Cl A

FMR
Vanguard Group
Baillie Gifford & Co
ARK Investment Management
BlackRock
Morgan Stanley
T. Rowe Price Associates
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Sands Capital Management
T. Rowe Price Investment Management
Venrock Management VI
Geode Capital Management
Credit Suisse
Bp Wealth Management

View all funds holding 10x Genomics Inc Cl A